Health

  • December 11, 2017

    Surgeon Tells Jury Complications Not Limited To J&J Mesh

    The chief of female pelvic medicine at Hackensack University Medical Center told a New Jersey jury Monday that research and her own hundreds of surgeries reveal complications can arise from all methods of pelvic prolapse repair, not just Johnson & Johnson unit Ethicon’s Prolift, which a woman alleges is responsible for debilitating pain.

  • December 11, 2017

    Ill. Firm Must Face Privacy Claims Over Deposition Disclosure

    An Illinois appeals court on Friday partially reversed and remanded a privacy lawsuit against Illinois firm Williams McCarthy LLP, whose lawyer was sued for improperly revealing the mental health status of a woman who claimed she was wrongfully excluded from a trust.

  • December 11, 2017

    Has Litigation Finance Shed Its Stigma?

    Once a taboo topic in the halls of BigLaw, litigation finance is winning over converts. And the peer pressure is building for rival law firms to join the bandwagon.

  • December 11, 2017

    What Your Colleagues Think Of Litigation Finance

    We asked, and you answered. Here are the results of Law360’s inaugural survey on third-party legal funding.

  • December 11, 2017

    Why Investors Are Taking The Leap To 3rd-Party Funding

    They often don’t know exactly what they’re buying, and there’s an ever-present chance they could come up empty in a given case. Here’s why investors are flocking to litigation finance anyway.

  • December 11, 2017

    Ex-Katten Atty's Expert Defends No-Work Consulting Deals

    An executive compensation expert on Monday told the jury in the fraud trial of former Katten Muchin Rosenman LLP attorney Evan Greebel that there’s nothing unusual about consulting deals that don’t involve much consulting, as the defense sought to refute a central theory of the government’s case.

  • December 11, 2017

    NLRB Partial Settlements Shift Is Trump Board's 1st Reversal

    The National Labor Relations Board said Monday that its judges can sign off on partial settlement proposals even if the agency’s general counsel and the charging party in a given case object, restoring the board’s “reasonableness” settlement standard in the Trump board’s first reversal of Obama-era policy.

  • December 11, 2017

    UnitedHealth Wants Out Of Medicare FCA Suit

    UnitedHealth Group Inc. on Friday urged a California federal court to scrap a False Claims Act suit claiming the insurer overcharged Medicare by submitting information that made patients seem sicker than they were, arguing the federal government knew about submission errors but didn’t consider them important.

  • December 11, 2017

    Retailers Defend Solodyn MDL Claims Against Medicis

    Walgreen Co., CVS Pharmacy Inc., Rite Aid Corp. and other retailers alleging Medicis Pharmaceutical Corp. paid generic-drug makers to stay out of the market for acne medication Solodyn urged a Massachusetts federal court Monday to reject Medicis' efforts to nix some of their claims.

  • December 11, 2017

    Convicted Pharmacist's Wife Wants To Keep Money, House

    The wife of a pharmacist convicted of racketeering and fraud related to a deadly 2012 meningitis outbreak has asked a Massachusetts federal court not to make her husband forfeit properties, a trust fund, multiple bank accounts and other assets, arguing they belong to her too.

  • December 11, 2017

    Noted Medical Malpractice Defense Atty Joins Dorf & Nelson

    A former Martin Clearwater & Bell LLP medical malpractice attorney has joined Dorf & Nelson LLP as a partner and will head its medical malpractice defense group in New York, the firm announced Monday.

  • December 11, 2017

    Deals Rumor Mill: Disney, Ascension Health, GGP

    A deal between Disney and 21st Century Fox could come this week, Ascension Health and Providence St. Joseph Health are in talks to merge, and GGP has declined Brookfield Property Partners LP’s $14.8 billion buyout bid.

  • December 11, 2017

    FDA Issues Final Guidance On Drug Names In Ads

    The U.S. Food and Drug Administration on Monday released final guidance laying out its recommendations for how product names are displayed on advertising and promotional labeling for prescription drugs, and proposed to study how consumers and health care providers spot deceptive ads.  

  • December 11, 2017

    Justices Won't Hear Appeal Of $8M Health Care Fraud Verdict

    The U.S. Supreme Court declined on Monday to hear an appeal brought by a medical diagnostics company owner sentenced to 10 years in prison after a jury found him guilty of Medicare and Medicaid fraud for billing $8 million for X-rays interpreted by amateurs, leading to the death of two patients.

  • December 11, 2017

    21st Century To Pay $28M Over Gov't FCA Claims, Data Breach

    21st Century Oncology on Monday got a New York bankruptcy court’s approval for two settlements totaling $28 million over U.S. government claims of Medicare overcharges and patient privacy breaches.

  • December 11, 2017

    NJ Board Revokes Doc's License For Prescription Abuse

    The New Jersey Board of Medical Examiners permanently revoked a Bergen County psychiatrist’s license after he was convicted of illicitly prescribing the stimulant Adderall, prosecutors announced on Friday.

  • December 11, 2017

    Kirkland Wins As Top Fees Earner In Caesars Ch. 11

    An Illinois bankruptcy court on Friday gave final approval to nearly $148 million in fees to various law firms and consultancies as part of Caesars Entertainment Operating Co. Inc.'s Chapter 11 process, awarding the largest amount — approximately $77 million — to Kirkland & Ellis LLP for guiding the casino giant through its reorganization.

  • December 8, 2017

    The Law Firms Of The 2017 MVPs

    Law360's MVP award goes to attorneys who have distinguished themselves from their peers in litigation, deals and other complex matters. Find the MVPs at your firm here.

  • December 8, 2017

    Law360 MVP Awards Go To Top Attorneys From 78 Firms

    The elite slate of attorneys chosen as Law360’s 2017 MVPs have distinguished themselves from their peers by securing hard-earned successes in high-stakes litigation, complex global matters and record-breaking deals.

  • December 8, 2017

    Texas Justices To Hear Challenge To $9.6M MedMal Verdict

    The Texas Supreme Court on Friday agreed to hear a case in which Obstetrical and Gynecological Associates and one of its doctors argue that there was legally insufficient evidence to support a $9.6 million jury award in favor of the husband of a woman who alleges the substandard care she received resulted in a brain injury.

Expert Analysis

  • Series

    40 Years Of FCPA: A Journey From Conviction To Dismissal

    Janet Levine

    The twist in the Lindsey Manufacturing Foreign Corrupt Practices Act case was the truncated time in which we prepared. Having refused to waive their rights to a speedy trial, our clients took control of the case — this, along with the compressed time frame, forced the government to make errors, say Janet Levine, Sima Namiri-Kalantari and Megan Weisgerber of Crowell & Moring LLP.

  • Leveling The Playing Field With The Jury Inference

    Peter Hargitai

    What happens when a litigant has no access to an opponent’s evidence because it has been destroyed or lost? Recently, the Supreme Court of Florida created a revised standard jury instruction, allowing juries to infer that missing evidence may be unfavorable to the party who lost or destroyed it. Practitioners should know how to use this tool, says Peter Hargitai of Holland & Knight LLP.

  • 'Tis The Season To Be Mindful Of Workplace Accommodations

    Courtney White

    As we prepare holiday to-do and shopping lists, employers should remember the legal obligations for recognizing, addressing and accommodating employees’ religious needs. Attorneys at Ogletree Deakins Nash Smoak & Stewart PC discuss five considerations to keep top of mind this season and year-round.

  • FCA Attention Turns To Electronic Health Records

    Jaime Jones

    The Centers for Medicare & Medicaid Services has committed significant resources toward encouraging health care providers to use electronic health records systems. Unsurprisingly, the increased adoption of EHR systems and the government’s subsidization thereof has attracted attention from relators filing qui tam suits under the False Claims Act, say Jaime Jones and Brenna Jenny of Sidley Austin LLP.

  • Series

    40 Years Of FCPA: The Siemens Lesson — Tillerson Is Right

    solmssen.jpg

    Since its whopping $800 million Foreign Corrupt Practices Act settlement in 2008, Siemens cleaned up — and it has “cleaned up” in its long-standing competition with General Electric. How? As Secretary of State Rex Tillerson reportedly told President Donald Trump, you don’t need to pay bribes to succeed in international business, says Peter Y. Solmssen, former general counsel of Siemens.

  • Series

    40 Years Of FCPA: The Rise In International Enforcement

    Scarboro.jpg

    The 2008 Siemens matter — then the largest sanction ever imposed in a Foreign Corrupt Practices Act enforcement action — set the stage for future cross-collaboration in global anti-corruption enforcement, say Cheryl Scarboro, former chief of the FCPA Unit at the U.S. Securities and Exchange Commission, and Diana Wielocha of Simpson Thacher & Bartlett LLP.

  • Is A Shift In DOJ Qui Tam Intervention Policy Coming?

    Brian McEvoy

    A U.S. Department of Justice official recently made a surprising policy announcement that has the potential to change the practice of attorneys involved in bringing and defending against qui tam lawsuits under the False Claims Act, say Brian McEvoy and Michael Besser of Polsinelli PC.

  • Series

    40 Years Of FCPA: Highlights From The 1st Corporate Trial

    Robert Feldman

    The Foreign Corrupt Practices Act case of U.S. v. Harris Corp. was tried in March 1991 — so long ago that pretty much only the parties and counsel remember it. With a smile, I’ve just about given up correcting people who say their case is "the only FCPA case ever to be tried,” says Robert Feldman of Quinn Emanuel Urquhart & Sullivan LLP.

  • Opinion

    Trump's Contraception Rules Suffer From Fatal Legal Flaws

    Nancy Northup

    As the comment period comes to a close Tuesday for the Trump administration’s interim final rules on contraception, the administration will start preparing final regulations — risking access to birth control coverage under the Affordable Care Act for thousands of women, says Nancy Northup, CEO of the Center for Reproductive Rights.

  • Congressional Forecast: December

    Richard Hertling

    Members of Congress face a daunting to-do list in the final weeks of 2017. While some believe a looming deadline will help get things done, there is worry on Capitol Hill that the legislative pileup and long-simmering partisan battles on major budget and policy issues have created a prime opportunity for political brinkmanship to paralyze the high-stakes negotiations, say Richard Hertling and Kaitlyn McClure of Covington & Burling LLP.